p32 regulates glycometabolism and TCA cycle to inhibit ccRCC progression via copper-induced DLAT lipoylation oligomerization

• Published in: International journal of biological sciences 2024, Vol.20 (2), p.516-536
• Main Authors: Tian, Shaoping, Wang, Rui, Wang, Yiting, Chen, Ruibing, Lin, Tianyu, Xiao, Xuesong, Liu, Xinyu, Ideozu, Justin Eze, Geng, Hua, Wang, Yong, Yue, Dan
• Format: Article
• Language: English
• Subjects: Research Paper
• ISSN: 1449-2288; 1449-2288
• DOI: 10.7150/ijbs.84399

A key player in mitochondrial respiration, p32, often referred to as C1QBP, is mostly found in the mitochondrial matrix. Previously, we showed that p32 interacts with DLAT in the mitochondria. Here, we found that p32 expression was reduced in ccRCC and suppressed progression and metastasis in ccRCC animal models. We observed that increasing p32 expression led to an increase in oxidative phosphorylation by interacting with DLAT, thus, regulating the activation of the pyruvate dehydrogenase complex (PDHc). Mechanistically, reduced p32 expression, in concert with DLAT, suppresses PDHc activity and the TCA cycle. Furthermore, our research discovered that p32 has a direct binding affinity for copper, facilitating the copper-induced oligomerization of lipo-DLAT specifically in ccRCC cells. This finding reveals an innovative function of the p32/DLAT/copper complex in regulating glycometabolism and the TCA cycle in ccRCC. Importantly, our research provides important new understandings of the underlying molecular processes causing the abnormal mitochondrial metabolism linked to this cancer.